Phase II study of radiotherapy and temsirolimus versus radiochemotherapy with temozolomide in patients with newly diagnosed glioblastoma without MGMT promoter hypermethylation (EORTC 26082) - Wick, Wolfgang; Platten, Michael; Wick, Antje (Clinical cancer research, 2016)
Gesehen am 27.07.2020